Cofoe to buy 60% of Hefei Kangjuren for $14.9M
What's the deal? CofoeDealroom has a profile for this one. Try Dealroom → (01187.HK) will acquire a combined 60% stake in Hefei Kangjuren Medical Device Technology Co., Ltd.Dealroom has a profile for this one. Try Dealroom → for US$13.7M. The Hong Kong-listed company signed an equity transfer agreement with seller Guo Bensheng on November 19, 2026, funding the deal from its own cash.
What's the endgame? Cofoe develops and sells medical devices and home health products. Taking majority control of Kangjuren, a medical device maker, extends its footprint in the sector.
The signal: The all-cash deal shows Cofoe using its balance sheet to consolidate smaller device makers under its brand, a route to faster growth than building new product lines from scratch.
Read more: sohu.com
Image credit: "211220-Z-EL858-0027" by New York National Guard, licensed under CC BY-ND 2.0